These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33320846)

  • 21. Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs.
    Borghardt JM; Weber B; Staab A; Kloft C
    AAPS J; 2015 Jul; 17(4):853-70. PubMed ID: 25845315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth.
    Axelsson I; Naumburg E; Prietsch SO; Zhang L
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010126. PubMed ID: 31194879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
    Dyer MJ; Halpin DM; Stein K
    BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.
    Thorsson L; Edsbäcker S; Källén A; Löfdahl CG
    Br J Clin Pharmacol; 2001 Nov; 52(5):529-38. PubMed ID: 11736861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
    Harrison TW; Wisniewski A; Honour J; Tattersfield AE
    Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study.
    Naikwade SR; Bajaj AN; Gurav P; Gatne MM; Singh Soni P
    AAPS PharmSciTech; 2009; 10(3):993-1012. PubMed ID: 19649711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
    O'Shea O; Stovold E; Cates CJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects.
    Harrison TW; Tattersfield AE
    Thorax; 2003 Mar; 58(3):258-60. PubMed ID: 12612308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
    Lipworth BJ
    Arch Intern Med; 1999 May; 159(9):941-55. PubMed ID: 10326936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.
    Janson C; Stratelis G; Miller-Larsson A; Harrison TW; Larsson K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3055-3064. PubMed ID: 29089754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics, Safety, and Tolerability of a New Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate Diskus(®) in Healthy Adults.
    Vutikullird AB; Gillespie M; Song S; Steinfeld J
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):207-14. PubMed ID: 26624976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs.
    Bäckman P; Arora S; Couet W; Forbes B; de Kruijf W; Paudel A
    Eur J Pharm Sci; 2018 Feb; 113():41-52. PubMed ID: 29079338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids.
    Daley-Yates PT; Aggarwal B; Plank M
    Adv Ther; 2024 May; 41(5):1995-2009. PubMed ID: 38532238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An interactive algorithm for the assessment of cumulative cortisol suppression during inhaled corticosteroid therapy.
    Krishnaswami S; Hochhaus G; Derendorf H
    AAPS PharmSci; 2000; 2(3):E22. PubMed ID: 11741238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children.
    Agertoft L; Pedersen S
    Am J Respir Crit Care Med; 2003 Oct; 168(7):779-82. PubMed ID: 12893646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Partial Differential Equation Approach to Inhalation Physiologically Based Pharmacokinetic Modeling.
    Boger E; Wigström O
    CPT Pharmacometrics Syst Pharmacol; 2018 Oct; 7(10):638-646. PubMed ID: 30084547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009471. PubMed ID: 25030198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
    Daley-Yates PT; Richards DH
    Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate.
    Allen A; Bareille PJ; Rousell VM
    Clin Pharmacokinet; 2013 Jan; 52(1):37-42. PubMed ID: 23184737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration of mucus and its impact within in vitro setups for inhaled drugs and formulations: Identifying the limits of simple vs. complex methodologies when studying drug dissolution and permeability.
    Radivojev S; Kargl L; Pinto JT; Swedrowska M; Malmlöf M; Meindl C; Forbes B; Gerde P; Paudel A; Fröhlich E
    Int J Pharm; 2024 Aug; 661():124455. PubMed ID: 38986963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.